Apotex Denied Summary Win In Cephalon Monopoly Suit

Apotex Denied Summary Win In Cephalon Monopoly Suit

A Pennsylvania federal judge on Tuesday refused to grant Apotex Inc. summary judgment that Cephalon Inc. had monopoly power over the market for modafinil, the active ingredient in the narcolepsy drug Provigil, saying that disputed issues exist that should ...read more

  • Tags: